Tangible Shareholders Equity: The value shareholders equity less intangible assets.
OKYO Pharma Limited Sponsored ADR (OKYO) had Tangible Shareholders Equity of $-5.55M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$3.67M |
|
$0.01M |
|
$0.01M |
|
$3.68M |
|
$9.23M |
|
-- |
|
-- |
|
$9.23M |
|
$-5.55M |
|
|
Tangible Shareholders Equity |
$-5.55M |
$-5.55M |
|
-- |
|
| Cash Flow Statement Financials | |
$-1.81M |
|
$-0.00M |
|
$2.66M |
|
$0.83M |
|
$1.56M |
|
$0.73M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|